Replies to post #662 on TG Therapeutics Inc (TGTX)

[lasers]

TGR-1202

http://ir.tgtherapeutics.com/releasedetail.cfm?ReleaseID=700800

TG Therapeutics will make up-front licensing payments and milestones based on early clinical development, and will be responsible for the costs of clinical development of the products through Phase II, after which TG Therapeutics and Rhizen will be jointly responsible for all development costs of the product. TG Therapeutics and Rhizen will each maintain an exclusive option, exercisable at specific times during development, for TG Therapeutics to license the rights to TGR-1202, in which case Rhizen would be eligible to receive upfront, development, and commercialization milestone payments in addition to milestone payments and royalties tied to net sales of the product, the aggregate of which could exceed $250 million. Rhizen shall maintain rights to manufacture and supply the product to TG Therapeutics, and TG Therapeutics will be responsible for all clinical and regulatory development for TGR-1202 globally.

[Ecomike]

It is in the Dec 2011, Jan 2012 SEC 8-Ks and 10-Qs. I do not recall the exact details, But I think he did a R/M and bought a huge bunch of convertible shares, that gave him 99% of the company for cash and the R/M. Then they swapped more convertibles (IIRC?) for the new drug rights, and a hoard of cash. They made several deals, and then they converted half the convertibles and did R/S at the same time. Before the R/S the thin float traded as high as $22/share in early 2012. The CEO bought retail shares at $2.25/share (IIRC) last year that set the bottom! Then they made some more deals. I think the CEO owns 50% or more the entire OS! And the OS is just 20 million shares. The old companies from the RM, share holders had less than 500,000 shares after the R/M, so the current float is either supper tiny, or the overseas people are slowly selling some now, the people we got the new drug rights from, but I doubt they have over 7 million shares. That is the best I can do from memory, on short notice.

The current CEO has a past, ex CEO of KERX!!!!

They are close to a Nasdaq uplisting!!!!!